Our clinical experiences of 6 gastroenteropancreatic neuroendocrine tumor (GEP NETs) patients with recurrent liver metastases

被引:0
|
作者
Nakamura, Shoko [1 ]
Tomisato, Kota [1 ]
Teramoto, Akira [1 ]
Kondo, Akiyuki [1 ]
Matsukawa, Shinobu [1 ]
Yabutani, Akira [1 ]
Iraha, Atsushi [1 ]
Kobashikawa, Kasen [1 ]
Nakamura, Masamoto [1 ]
Nakayoshi, Tomokuni [1 ]
Uchima, Nobufumi [1 ]
Kinjo, Fukunori [1 ]
机构
[1] Urasoe Gen Hosp, Urasoe City, Japan
关键词
neuroendocrine tumor; liver metastases;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P-623
引用
收藏
页码:258 / 258
页数:1
相关论文
共 50 条
  • [21] Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
    Phillips, William J.
    Pradier, Michelle
    Goodwin, Rachel
    Vickers, Michael
    Asmis, Tim
    CURRENT ONCOLOGY, 2024, 31 (02) : 952 - 961
  • [22] Clinical epidemiology study of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): A 10-year retrospective study in China
    Yan, H.
    Jiang, L.
    Yang, H.
    Chi, Y.
    Fan, J.
    Qiao, Y.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 83 - 83
  • [23] Tumor growth rate in well-differentiated G1-3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Implications for clinical trials
    Wang, S.
    Whitman, J.
    Paciorek, A.
    Le, B. K.
    Zhang, L.
    Hope, T.
    Bergsland, E.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 116 - 116
  • [24] Dynamic enhanced CT: is there a difference between liver metastases of gastroenteropancreatic neuroendocrine tumor and adenocarcinoma
    Cui, Yong
    Li, Zhong-Wu
    Li, Xiao-Ting
    Gao, Shun-Yu
    Li, Ying
    Li, Jie
    Zhu, Hui-Ci
    Tang, Lei
    Cao, Kun
    Sun, Ying-Shi
    ONCOTARGET, 2017, 8 (64) : 108146 - 108155
  • [25] Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy
    Aya Maekawa
    Atsushi Kudo
    Mitsuhiro Kishino
    Yoshiki Murase
    Shuichi Watanabe
    Yoshiya Ishikawa
    Hiroki Ueda
    Keiichi Akahoshi
    Kosuke Ogawa
    Hiroaki Ono
    Shinji Tanaka
    Yuko Kinowaki
    Minoru Tanabe
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 697 - 706
  • [26] Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy
    Maekawa, Aya
    Kudo, Atsushi
    Kishino, Mitsuhiro
    Murase, Yoshiki
    Watanabe, Shuichi
    Ishikawa, Yoshiya
    Ueda, Hiroki
    Akahoshi, Keiichi
    Ogawa, Kosuke
    Ono, Hiroaki
    Tanaka, Shinji
    Kinowaki, Yuko
    Tanabe, Minoru
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (03) : 697 - 706
  • [27] The Role of Chemotherapy in the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The Large Experience of the Spanish National Tumor Registry (RGETNE)
    Garcia-Carbonero, R.
    Capdevila, J.
    Jimenez-Fonseca, P.
    Alonso, V
    Pachon, V
    Sevilla, I
    Sastre, J.
    Llanos, M.
    Castano, A.
    Salazar, R.
    NEUROENDOCRINOLOGY, 2012, 96 : 31 - 32
  • [28] Chromogranin A (CgA) serum levels correlate with hepatic tumor burden in patients with neuroendocrine gastroenteropancreatic (GEP) tumors
    Rinke, A
    Wilke, A
    Mayer, C
    Scherag, A
    Klose, KJ
    Arnold, R
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 45 - 45
  • [29] Survivin protein detection is a promising biomarker in the serum of gastroenteropancreatic neuroendocrine tumor (GEP-NET) patients
    Georgieva, Inna
    Hein, Sibyll
    Wang, Yawen
    Kiewe, Philipp
    Hopfenmuller, Werner
    Blaker, Michael
    Zeitz, Martin
    Grabowski, Patricia
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [30] Molecular and clinical profiling of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs): An analysis of the Oncology Research Information Exchange Network database.
    Ueberroth, Benjamin Edward
    Robinson, Hannah Ruth
    Davis, S. Lindsey
    Lieu, Christopher Hanyoung
    Balmaceda, Nicole Baranda
    Hayden, Alexander
    Leal, Alexis Diane
    Kim, Sunnie S.
    Lentz, Robert William
    Messersmith, Wells A.
    Toegel, Emily Baiyee
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 669 - 669